Procter & Gamble Hygiene and Health Care Ltd
PGHH NSE
Procter & Gamble Hygiene and Health Care Ltd
Consumer GoodsNSE: PGHH BSE: 500459 Personal Care
Key Fundamentals
SmallcapPersonal CareConsumer GoodsMarket Cap
₹27,183 Cr
Volatility
Moderate
P/E Ratio
34.14
EBITDA
₹1,162 Cr
Return on Equity
86.38%
Debt to Equity
0
Book Value
₹232.12
EPS
₹229.57
52W High
₹14,509
52W Low
₹8,361
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Procter & Gamble Hygiene and Health Care Ltd insights
34 extracted metrics + investor summaries across FY11–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 89.4%
- Company has been maintaining a healthy dividend payout of 91.5%
Weaknesses
2- Stock is trading at 36.0 times its book value
- The company has delivered a poor sales growth of 7.40% over past five years.
Growth Rate
Revenue Growth
25.49% ↗
Net Income Growth
35.54% ↗
Cash Flow Change
26.21% ↗
ROE
-0.85% ↘
ROCE
-6.71% ↘
EBITDA Margin (Avg.)
0.94% ↗
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 2d agoAI opinion · based on fundamentals
Risk medium
Procter & Gamble Hygiene and Health Care Ltd trades at a market cap of ₹27,523 Cr with a PE of 34.8x and an exceptionally high ROE averaging 89% over 3 years, but faces headwinds from declining sales (TTM sales growth of -2%) and a stock price that has fallen 36% over the past year.
Bull Case 7
- Exceptional return on equity with 3-year average ROE of 89% and last year ROE of 115%, indicating highly efficient capital deployment
- Virtually debt-free balance sheet, reducing financial risk and interest burden
- Consistent dividend payout ratio of 91.5% with a current dividend yield of 3%, providing reliable income to shareholders
- Compounded profit growth of 15% over 5 years and 14% over 3 years demonstrates strong earnings expansion
- Backed by global parent Procter & Gamble with strong brand portfolio in hygiene and health care categories in India
- 10-year compounded sales growth of 6% shows long-term revenue traction in a large consumer market
- 10-year compounded profit growth of 9% alongside improving margin trajectory (profit growth consistently exceeding sales growth)
Bear Case 8
- Stock is trading at 36.6x book value (PB of 36.57), an extremely elevated valuation relative to tangible assets
- TTM sales growth has turned negative at -2%, signaling potential demand slowdown or category headwinds
- Stock price has declined 36% over 1 year and 18% CAGR decline over 3 years, reflecting sustained investor de-rating
- 5-year sales CAGR of only 7.4% is poor for a consumer goods company operating in a high-growth emerging market
- PE ratio of 34.8x is elevated given the negative near-term sales and profit trajectory (TTM profit growth of -5%)
- 10-year stock CAGR of just 2% suggests prolonged value destruction relative to broader market returns
- High dividend payout of 91.5% leaves minimal retained earnings for reinvestment and organic growth initiatives
- Limited product diversification compared to global parent, with narrow India portfolio concentrated in feminine hygiene and health care segments
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 19h ago Headwinds 1
- Q1FY26 profit slides 34% YoY Jul 29
Net profit dropped 34% YoY to ₹126.27 crore in Q1FY26, driven by higher advertising costs and lower revenue.
Neutral 1
- AGM and dividend record date set Aug 7
Record date fixed for September 1, 2026 for dividend payment. 62nd AGM scheduled for September 8, 2026.
TL;DR: P&G Hygiene faces near-term earnings pressure with a sharp 34% profit decline in Q1FY26 due to elevated ad spend and softer revenue. The company continues returning capital to shareholders via dividends. The trend is deteriorating on profitability and investors should watch whether revenue growth recovers in coming quarters to justify the higher marketing investment.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 853 | 1,138 | 1,133 | 1,002 | 932 | 1,135 | 1,248 | 992 | 937 | 1,150 | 1,262 | 941 | 891 |
| Expenses | 638 | 853 | 824 | 745 | 813 | 845 | 877 | 782 | 671 | 865 | 860 | 723 | 721 |
| Operating Profit | 215 | 285 | 310 | 257 | 118 | 290 | 371 | 210 | 266 | 285 | 402 | 218 | 170 |
| OPM % | 25% | 25% | 27% | 26% | 13% | 26% | 30% | 21% | 28% | 25% | 32% | 23% | 19% |
| Other Income | 10 | 16 | 16 | 14 | 7 | 8 | 10 | 19 | 8 | 10 | 12 | 12 | 9 |
| Interest | 3 | 2 | 3 | 22 | 0 | 2 | 7 | 6 | 0 | 4 | 3 | 3 | 0 |
| Depreciation | 15 | 14 | 14 | 15 | 13 | 12 | 10 | 10 | 9 | 9 | 10 | 10 | 10 |
| PBT | 207 | 284 | 309 | 234 | 112 | 285 | 364 | 213 | 265 | 282 | 402 | 218 | 170 |
| Tax % | 27% | 26% | 26% | 34% | 28% | 26% | 26% | 27% | 27% | 26% | 25% | 30% | 26% |
| Net Profit | 151 | 211 | 229 | 154 | 81 | 212 | 269 | 156 | 192 | 210 | 301 | 153 | 126 |
| EPS in Rs | 46.59 | 64.91 | 70.52 | 47.56 | 24.97 | 65.28 | 82.74 | 48.09 | 59.17 | 64.65 | 92.87 | 47.17 | 38.9 |
Profit & Loss
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 9m | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,334 | 2,275 | 2,320 | 2,455 | 2,947 | 3,002 | 3,574 | 3,901 | 3,918 | 4,206 | 3,374 | 4,290 | 4,245 |
| Expenses | 1,838 | 1,667 | 1,646 | 1,834 | 2,329 | 2,396 | 2,688 | 3,069 | 3,048 | 3,230 | 2,503 | 3,119 | 3,170 |
| Operating Profit | 495 | 608 | 675 | 622 | 618 | 606 | 886 | 832 | 869 | 976 | 871 | 1,171 | 1,075 |
| OPM % | 21% | 27% | 29% | 25% | 21% | 20% | 25% | 21% | 22% | 23% | 26% | 27% | 25% |
| Other Income | 64 | 85 | 67 | 18 | 45 | 42 | 38 | 23 | 40 | 47 | 37 | 42 | 44 |
| Interest | 6 | 6 | 10 | 5 | 5 | 6 | 6 | 11 | 11 | 27 | 14 | 9 | 10 |
| Depreciation | 53 | 52 | 60 | 52 | 50 | 48 | 48 | 53 | 58 | 56 | 32 | 37 | 38 |
| PBT | 501 | 636 | 672 | 582 | 607 | 594 | 870 | 790 | 839 | 939 | 862 | 1,167 | 1,072 |
| Tax % | 31% | 34% | 36% | 36% | 31% | 27% | 25% | 27% | 19% | 28% | 26% | 27% | — |
| Net Profit | 346 | 422 | 433 | 375 | 419 | 433 | 652 | 576 | 678 | 675 | 637 | 856 | 791 |
| EPS in Rs | 107 | 130 | 133 | 115 | 129 | 133 | 201 | 177 | 209 | 208 | 196 | 264 | 244 |
| Div. Payout % | 28% | 28% | 292% | 35% | 68% | 79% | 157% | 90% | 89% | 123% | 89% | 97% | — |
Balance Sheet
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 1,196 | 1,619 | 494 | 773 | 877 | 1,125 | 682 | 705 | 914 | 742 | 705 | 721 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 4 | 3 | 2 | 1 |
| Other Liabilities | 719 | 515 | 634 | 620 | 708 | 671 | 915 | 940 | 1,187 | 1,081 | 1,015 | 1,049 |
| Total Liabilities | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
| Fixed Assets | 309 | 317 | 286 | 250 | 234 | 206 | 184 | 164 | 170 | 139 | 131 | 163 |
| CWIP | 39 | 35 | 41 | 21 | 15 | 22 | 38 | 44 | 23 | 28 | 41 | 21 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,600 | 1,814 | 834 | 1,154 | 1,368 | 1,600 | 1,411 | 1,475 | 1,945 | 1,692 | 1,583 | 1,619 |
| Total Assets | 1,948 | 2,166 | 1,160 | 1,425 | 1,617 | 1,828 | 1,633 | 1,683 | 2,137 | 1,859 | 1,755 | 1,804 |
Cash Flow
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 426 | 352 | 445 | 415 | 413 | 474 | 863 | 573 | 826 | 470 | 593 | 924 |
| Investing | 28 | 221 | 149 | -19 | 34 | 75 | 7 | -27 | -10 | 1 | -34 | 11 |
| Financing | -105 | -122 | -1,559 | -106 | -314 | -190 | -1,106 | -569 | -477 | -861 | -666 | -845 |
| Net Cash Flow | 349 | 452 | -964 | 290 | 134 | 358 | -236 | -23 | 339 | -390 | -107 | 91 |
| Free Cash Flow | 348 | 300 | 401 | 377 | 410 | 423 | 832 | 523 | 781 | 427 | 539 | 893 |
| CFO/OP | 127 | 91 | 103 | 111 | 105 | 102 | 126 | 99 | 121 | 79 | 96 | 105 |
Ratios
| Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 24 | 21 | 22 | 22 | 20 | 15 | 18 | 20 | 21 | 33 | 21 |
| Inventory Days | 47 | 53 | 71 | 48 | 60 | 68 | 78 | 55 | 48 | 51 | 64 | 51 |
| Days Payable | 148 | 134 | 145 | 156 | 162 | 175 | 237 | 183 | 213 | 193 | 235 | 197 |
| Cash Conversion Cycle | -83 | -57 | -53 | -87 | -79 | -87 | -144 | -110 | -145 | -121 | -138 | -126 |
| Working Capital Days | 4 | 8 | -15 | -23 | -12 | -21 | -39 | -34 | -53 | -32 | -31 | -31 |
| ROCE % | 46% | 45% | 64% | 89% | 73% | 58% | 94% | 110% | 101% | 112% | 104% | 157% |
Documents
1
Clarification sought from Procter & Gamble Hygiene and Health Care Ltd
19 Jun - Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd on June 19, 2026, with reference to Movement in Volume. 19 Jun - Exchange has sought clarification from Procter & Gamble Hygiene and Health Care Ltd on June 19, 2026, with reference to Movement in Volume.
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Company has submitted Certificate under regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026 10 Apr - Company has submitted Certificate under regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2026
3
Intimation Regarding Ease Of Doing Business - Special Window For Transfer And Dematerialization Of Physical Securities
7 Apr - SEBI special window for re-lodgement of physical shares extended to February 4, 2027. 7 Apr - SEBI special window for re-lodgement of physical shares extended to February 4, 2027.
4
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
6 Apr - Company says it is not a SEBI Large Corporate; outstanding borrowing was nil on March 31, 2026. 6 Apr - Company says it is not a SEBI Large Corporate; outstanding borrowing was nil on March 31, 2026.
5
Closure of Trading Window
27 Mar - Trading window closed for directors/designated employees from April 1, 2026 until 48 hours after audited FY2026 results publication. 27 Mar - Trading window closed for directors/designated employees from April 1, 2026 until 48 hours after audited FY2026 results publication.
1
Notice Of Annual General Meeting Of The Company Scheduled To Be Held On September 8 2026 17 Aug 2026
Intimation
Frequently Asked Questions about Procter & Gamble Hygiene and Health Care Ltd
What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care bran...
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd is listed on the Indian stock exchanges. It is listed on NSE: PGHH and BSE: 500459. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd operates in the Consumer Goods sector within the Personal Care industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of approximately ₹27182.62 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
The Price-to-Earnings (PE) ratio of Procter & Gamble Hygiene and Health Care Ltd is 34.14. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the past 52 weeks, Procter & Gamble Hygiene and Health Care Ltd has traded between a low of ₹8,361 and a high of ₹14,509. This range helps investors understand the stock's price volatility and recent trading levels.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Yes, Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 3.05%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a Return on Equity (ROE) of 86.38%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Procter & Gamble Hygiene and Health Care Ltd on Tapetide?
On Tapetide, you can view Procter & Gamble Hygiene and Health Care Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.